We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. What is new in the classification of peripheral T cell lymphomas?

    In this review focus article, we highlight the main modifications introduced in the latest 2022 International Consensus Classification and World...

    Laurence de Leval, Bettina Bisig in Die Pathologie
    Article Open access 04 December 2023
  2. Central Nervous System Relapse in T and NK cell Lymphomas

    Purpose of Review

    T and NK cell lymphomas are relatively rare and heterogeneous forms of non-Hodgkin lymphoma that are associated with high rates of...

    Eleanor P. Taranto, Stefan K. Barta, Rahul S. Bhansali in Current Hematologic Malignancy Reports
    Article 25 August 2023
  3. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders

    Purpose of Review

    Mature T/NK-cell neoplasms comprise a heterogeneous group of diseases with diverse clinical, histopathologic, immunophenotypic, and...

    Naoki Oishi, Reham Ahmed, Andrew L. Feldman in Current Hematologic Malignancy Reports
    Article 23 October 2023
  4. Mature T-cell and NK-cell lymphomas: updates on molecular genetic features

    Mature T-cell and NK-cell lymphomas are a heterogeneous group of rare and typically aggressive neoplasms. Diagnosis and subclassification have...

    Natasha E. Lewis, Rohan Sardana, Ahmet Dogan in International Journal of Hematology
    Article 13 January 2023
  5. Extranodal T- and NK-cell lymphomas

    Non-cutaneous extranodal NK/T cell lymphoproliferations constitute a heterogenous group of rare neoplasms, occurring primarily in the...

    Laurence de Leval, Andrew L. Feldman, ... Philippe Gaulard in Virchows Archiv
    Article Open access 07 November 2022
  6. Moving towards biologically informed treatment strategies for T-cell lymphomas

    The rarity and biological heterogeneity of the peripheral T-cell lymphomas has made subtype- and biomarker-driven approaches challenging to realize...

    Robert Stuver, Natasha Lewis, ... Steven M. Horwitz in International Journal of Hematology
    Article 27 December 2022
  7. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas

    Nodal T- and NK-cell lymphomas are among the most frequent T-cell malignancies and most subtypes have aggressive clinical behavior. Evolving...

    Andrew L. Feldman, Camille Laurent, ... Philippe Gaulard in Virchows Archiv
    Article 10 October 2022
  8. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop

    Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases were discussed at the 2022 European Association for...

    Fina Climent, Alina Nicolae, ... Siok-Bian Ng in Virchows Archiv
    Article Open access 30 August 2023
  9. Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas

    Purpose

    The purpose of the study was to evaluate the prognostic value of low T3 syndrome in peripheral T-cell lymphomas (PTCLs).

    Methods ...
    Wenyi Li, Rui Gao, ... Wei Xu in Clinical and Translational Oncology
    Article 18 July 2023
  10. How we treat NK/T-cell lymphomas

    Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein–Barr virus...

    Eric Tse, Wei-Li Zhao, ... Yok-Lam Kwong in Journal of Hematology & Oncology
    Article Open access 03 June 2022
  11. First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology

    Purposeof Review

    The main aim of this review is to summarize first-line therapy of nodal T-cell non-Hodgkin lymphoma.

    Recent Findings

    Current...

    Vibor Milunović, Inga Mandac Smoljanović, ... Slavko Gašparov in Current Oncology Reports
    Article 12 April 2023
  12. Management of Peripheral T-cell Lymphomas and the Role of Transplant

    Purpose of Review

    Here, we review the management of peripheral T-cell lymphoma, particularly focusing on the role of autologous and allogeneic stem...

    Nicole C. Foley, Neha Mehta-Shah in Current Oncology Reports
    Article 10 August 2022
  13. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas

    The aim of the study was to explore the significance and prognostic value of 25-hydroxy vitamin D (25-(OH) D) deficiency in peripheral T-cell...

    Hao-Rui Shen, **g Tang, ... Wei Xu in Annals of Hematology
    Article 11 November 2023
  14. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

    Follicular helper T-cell lymphomas (TFH lymphomas) were discussed in session V of the lymphoma workshop of the European Association for...

    Sarah L Ondrejka, Catalina Amador, ... Laurence de Leval in Virchows Archiv
    Article Open access 27 July 2023
  15. Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study

    The aim of this study is to evaluate the survival benefit of consolidative autologous hematopoietic stem cell transplantation (ASCT) in patients with...

    Meng Wu, Fengrong Wang, ... Jun Zhu in Annals of Hematology
    Article Open access 12 September 2023
  16. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region

    Among primary cutaneous T-cell lymphomas (CTCL), mycosis fungoides (MF) is the most frequent and, along with Sézary syndrome (SS), the best-studied...

    Alessandro Pileri, Erika Morsia, ... Serena Rupoli in European Journal of Dermatology
    Article 01 July 2023
  17. Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas

    Primary cutaneous γδ T-cell lymphoma (PCGDTL) is a rare subtype of non-Hodgkin lymphoma (NHL) that arises from T-cells with γδ T-cell receptors. The...

    Ibrahim N. Muhsen, Riad El Fakih, ... Mahmoud Aljurf in Clinical Hematology International
    Article Open access 22 June 2022
  18. Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas

    Chimeric antigen receptor T-cell therapy (CAR-T) is a revolutionary advancement in the management of chemotherapy refractory B-cell non-Hodgkin...

    Anagha Deshpande, William Rule, Allison Rosenthal in Current Treatment Options in Oncology
    Article 01 January 2022
  19. Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis

    There have recently been a few case reports of cutaneous T-cell lymphomas following treatment of atopic dermatitis with dupilumab, which works...

    Kumi Nakazaki, Mina Yoshida, ... Mineo Kurokawa in International Journal of Hematology
    Article 30 March 2022
  20. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up

    Peripheral T-cell lymphomas are a heterogeneous, and usually aggressive, group of mature T-cell neoplasms with overlap** clinical, morphologic and...

    Francisco Vega, Catalina Amador, ... Andrew L. Feldman in Modern Pathology
    Article 28 September 2021
Did you find what you were looking for? Share feedback.